Αποτελέσματα Αναζήτησης
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
ICON has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotech
1 Ιουλ 2021 · Dublin, Ireland, 1st July 2021 – ICON plc, (NASDAQ: ICLR) today announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and clinical research organisation.
ICON Careers. We encourage our people to seize the opportunity to bring flexibility, innovation and determination to every situation. By doing this, our people build exciting and rewarding careers, deliver results to help bring life-changing medicines and devices to market and maintain ICON’s success as an industry leader. View jobs at ICON
From the moment you start in a new position with ICON, you’re encouraged to grow beyond it. The time and resources we devote to helping our employees develop isn’t an expense, it’s an investment.
ICON acquires Symphony Clinical Research, a leading provider of at-home patient services and site support services. ICON acquires MediNova, an integrated network of clinical research sites across EMEA. ICON acquires MolecularMD to enhance laboratory offering in molecular diagnostic testing and immunohistochemistry
Dr. Greg Licholai is Chief Medical and Innovation Officer at ICON plc, a global healthcare intelligence and clinical research organisation. He is on the faculty at Yale School of Management and is Co-Director of the Center for Digital Health.
ICON provides its full range of clinical, consulting and commercial services across several industry sectors.
ICON has worked with many of the world’s pharmaceutical firms, developing strategic partnerships with some of the world’s largest.
